Preluent Trademark Details

Preluent was registered on Tuesday, July 15, 2014 and is currently owned by Sanofi Biotechnology under the registration number 4566771 . This mark is alive with a status of Registered. The last case file activity for this mark occured 9 years ago on Tuesday, July 15, 2014, according to the United State Patent & Trademark Office
Word Mark Preluent
Status Alive Registered 700 — Registered

Current Owner

Sanofi Biotechnology

View all trademarks for Sanofi Biotechnology

Previous Owners

Sanofi of Paris, TX

View all trademarks for Sanofi
Other Trademarks for Sanofi
Serial Number 86019033
Registration Number 4566771
Status Date Tuesday, July 15, 2014
Filing Date Tuesday, July 15, 2014
Registration Date Tuesday, July 15, 2014
Attorney Susan Upton Douglass
Domestic Representative Susan Upton Douglass

Correspondent

SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK, NY 10017-1822

Case File Statements

Goods & Services Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; vitamins being pharmaceutical preparations; hormone preparations being pharmaceutical preparations for medical purposes

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, July 30, 2013
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.